Evidence map›Paper›PMID 35255298›Full record

ArticleVirology2022

Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination.

Xuemin Chen, He-Ying Sun, Chun Yi Lee, Christina A Rostad, Jessica Trost, Rodrigo B Abreu, Michael A Carlock, Jason R Wilson, Shane Gansebom, Ted M Ross and 3 more

Open access · greenAbstract read
In one paragraph

Article in Virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Xuemin ChenDivision of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States; Emory-UGA Center of Excellence of Influenza Research and Surveillance (CEIRS), Atlanta, GA, USA.
He-Ying SunDivision of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States; Emory-UGA Center of Excellence of Influenza Research and Surveillance (CEIRS), Atlanta, GA, USA.
Chun Yi LeeDivision of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
Christina A RostadDivision of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States.
Jessica TrostEmory-UGA Center of Excellence of Influenza Research and Surveillance (CEIRS), Atlanta, GA, USA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, United States; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
Rodrigo B AbreuCenter for Vaccines and Immunology, University of Georgia, Athens, GA, United States; Emory-UGA Center of Excellence of Influenza Research and Surveillance (CEIRS), Athens, GA, USA.
Michael A CarlockCenter for Vaccines and Immunology, University of Georgia, Athens, GA, United States; Emory-UGA Center of Excellence of Influenza Research and Surveillance (CEIRS), Athens, GA, USA.
Jason R WilsonMolecular Virology and Vaccine Team, Influenza and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Disease, OID, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Shane GansebomMolecular Virology and Vaccine Team, Influenza and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Disease, OID, Centers for Disease Control and Prevention, Atlanta, GA, United States; (CDC/DDID/NCIRD/ID) GDIT, Federal Civilian Division, 2 Corporate Square; Ste 100, Atlanta, GA, 30329, USA.
Ted M RossCenter for Vaccines and Immunology, University of Georgia, Athens, GA, United States; Emory-UGA Center of Excellence of Influenza Research and Surveillance (CEIRS), Athens, GA, USA; Department of Infectious Diseases, University of Georgia, Athens, GA, United States.
David A SteinhauerEmory-UGA Center of Excellence of Influenza Research and Surveillance (CEIRS), Atlanta, GA, USA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, United States.
Evan J AndersonDivision of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.
Larry J AndersonDivision of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, United States; Emory-UGA Center of Excellence of Influenza Research and Surveillance (CEIRS), Atlanta, GA, USA. Electronic address: larry.anderson@emory.edu.
Emory University · USUniversity of Georgia · USCenters for Disease Control and Prevention · US

Funding

NIAID NIH HHS HHSN272201400004C
6 · The paper itself

Abstract

Novel cell-based assays were developed to assess antibody-dependence cellular cytotoxicity (ADCC) antibodies against both vaccine and a representative circulation strain HA and NA proteins for the 2014-15 influenza season. The four assays using target cells stably expressing one of the four proteins worked well. In pre- and post-vaccine sera from 70 participants in a pre-season vaccine trial, we found ADCC antibodies and a rise in ADCC antibody titer against target cells expressing the 4 proteins but a much higher titer for the vaccine than the circulating HA in both pre-and post-vaccine sera. These differences in HA ADCC antibodies were not reflected in differences in HA binding antibodies. Our observations suggested that relatively minor changes on the subtype HA can result in large differences in ADCC activity.

Indexed as

Influenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesAntibodies, ViralAntibody-Dependent Cell CytotoxicityCross ReactionsHemagglutinin Glycoproteins, Influenza VirusHumansVaccinationAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesAntibody-dependent cellular cytotoxicity (ADCC)Influenza hemagglutinin (HA)Influenza neuraminidase (NA)Influenza virus vaccine

Identifiers

PMID35255298
PMCPMC9013517
OpenAlexW4213455042

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.